Olympus announced today that it closed its acquisition of Taewoong Medical, a Korea-based medical device manufacturer. Taewoong Medical develops gastrointestinal (GI) metallic stents, among other offerings. Olympus announced its intent to acquire the company for $370 million in February 2023. The deal includes $255.5 million upfront, with up to $114.5 million in potential milestone payments […]
Structural Heart
Abbott reports double-digit growth across Medical Devices in Q4 as Diabetes, EP lead the way
Abbott today reported fourth-quarter earnings that included double-digit revenue growth across its entire Medical Devices unit. Shares of ABT fell more than 2% to nearly $111 apiece in morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down slightly. The Abbott Park, Illinois–based medtech giant […]
FDA grants breakthrough nod for Pi-Cardia leaflet modification device for TAVR
Pi-Cardia announced today that the FDA granted breakthrough device designation for its ShortCut leaflet modification device. ShortCut facilitates valve-in-valve transcatheter aortic valve replacement (TAVR) procedures in patients at risk of coronary obstruction. Rehovot, Israel–based Pi-Carda earned the breakthrough nod after completing enrollment in a U.S. and European pivotal study last September. The leaflet modification system […]
Cardiac Dimensions has a new chief medical officer
Cardiac Dimensions announced today that it appointed Dr. Satya Shreenivas as its new chief medical officer (CMO). Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatments for heart failure with functional mitral regurgitation (FMR). That includes the Carillon Mitral Contour System, for which the company has the ongoing EMPOWER trial. Its new CMO served as an […]
Gore enrolls first patients in expandable stent graft trial
W.L. Gore & Associates announced today that it enrolled the first patients in a trial evaluating its Viabahn VBX stent graft. The study compares Gore’s balloon-expandable endoprosthesis to bare metal stenting for patients with complex iliac occlusive disease. It aims to inform practice guidelines around the best modalities suited for patients with this condition. Dr. […]
Medtronic brings back former VP as GM of Aortic unit
Medtronic announced that it named Dr. Simona Zannetti as the GM of its Aortic business unit. Zannetti previously spent 21 years at the medtech giant. She spent the last 16 months as SVP of clinical research at Penumbra, joining the interventional device maker in September 2022. In a LinkedIn post today, Nina Goodheart, SVP and […]
The biggest stories from the 2024 J.P. Morgan Healthcare Conference
Some of the biggest names in medtech came together this week at the J.P. Morgan Healthcare Conference. They shared updates on financial progress, operational changes and new products, among other things. Medtronic shared details on plans to restore earnings power, while Abbott highlighted the success of its FreeStyle Libre system. Shockwave Medical outlined its plans […]
Medtronic CEO: ‘Our top priority is restoring our earnings power — full stop.’
Medtronic Chair and CEO Geoff Martha focused on the push for profits at the world’s largest medical device manufacturer in his presentation at the J.P. Morgan Healthcare Conference today. “Our top priority is restoring our earnings power — full stop,” he said, citing Medtronic’s recent reorganizations and changes to incentives, product approvals and launches, and […]
Orchestra BioMed begins pivotal trial of cardiac neuromod tech
Orchestra BioMed (Nasdaq:OBIO) announced today that it randomized the first patient in a clinical trial of its AVIM therapy. The company’s BackBeat CNT atrioventricular interval modulation (AVIM) therapy treats pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. New Hope, Pennsylvania-based Orchestra Biomed’s BACKBEAT pivotal study evaluates the efficacy and safety of AVIM […]
Endotronix submits pulmonary artery sensor for FDA premarket approval
Endotronix announced today that it submitted a premarket approval (PMA) application to the FDA for its Cordella system. Cordella, a pulmonary artery (PA) sensor system, enables proactive, data-driven heart failure (HF) management. It engages patients, reduces and prevents congestion and improves outcomes. The Cordella system delivers proactive PA pressure data and non-invasive vital health data […]
Medtronic wins CE mark for next-gen Micra leadless pacemakers
Medtronic announced today that it received CE mark approval for its next-generation Micra AV2 and Micra VR2 miniature, leadless pacemakers. CE mark follows FDA approval for both devices in May of last year. The pacemakers — which Medtronic labels as the world’s smallest — provide longer battery life and easier programming than earlier versions. Micra […]